Copyright Reports & Markets. All rights reserved.

Global Nanobody Discovery Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Nanobody Discovery Service by Type
    • 1.3.1 Overview: Global Nanobody Discovery Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Nanobody Discovery Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Screening and Development Services
    • 1.3.4 Engineering and Optimization Services
    • 1.3.5 Production and Expression Services
    • 1.3.6 Other Services
  • 1.4 Global Nanobody Discovery Service Market by Application
    • 1.4.1 Overview: Global Nanobody Discovery Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Drug Discovery
    • 1.4.3 Biological Engineering
    • 1.4.4 Clinical Diagnosis
    • 1.4.5 Immune Research
    • 1.4.6 Others
  • 1.5 Global Nanobody Discovery Service Market Size & Forecast
  • 1.6 Global Nanobody Discovery Service Market Size and Forecast by Region
    • 1.6.1 Global Nanobody Discovery Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Nanobody Discovery Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Nanobody Discovery Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Nanobody Discovery Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Nanobody Discovery Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Nanobody Discovery Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Nanobody Discovery Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Creative Biolabs
    • 2.1.1 Creative Biolabs Details
    • 2.1.2 Creative Biolabs Major Business
    • 2.1.3 Creative Biolabs Nanobody Discovery Service Product and Solutions
    • 2.1.4 Creative Biolabs Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Creative Biolabs Recent Developments and Future Plans
  • 2.2 Curia
    • 2.2.1 Curia Details
    • 2.2.2 Curia Major Business
    • 2.2.3 Curia Nanobody Discovery Service Product and Solutions
    • 2.2.4 Curia Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Curia Recent Developments and Future Plans
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Nanobody Discovery Service Product and Solutions
    • 2.3.4 Sanofi Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sanofi Recent Developments and Future Plans
  • 2.4 NanoTag Biotechnologies
    • 2.4.1 NanoTag Biotechnologies Details
    • 2.4.2 NanoTag Biotechnologies Major Business
    • 2.4.3 NanoTag Biotechnologies Nanobody Discovery Service Product and Solutions
    • 2.4.4 NanoTag Biotechnologies Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 NanoTag Biotechnologies Recent Developments and Future Plans
  • 2.5 Shanghai Medicilon Inc.
    • 2.5.1 Shanghai Medicilon Inc. Details
    • 2.5.2 Shanghai Medicilon Inc. Major Business
    • 2.5.3 Shanghai Medicilon Inc. Nanobody Discovery Service Product and Solutions
    • 2.5.4 Shanghai Medicilon Inc. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Shanghai Medicilon Inc. Recent Developments and Future Plans
  • 2.6 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
    • 2.6.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Details
    • 2.6.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Major Business
    • 2.6.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product and Solutions
    • 2.6.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments and Future Plans
  • 2.7 Yeasen Biotechnology(Shanghai)Co.,Ltd.
    • 2.7.1 Yeasen Biotechnology(Shanghai)Co.,Ltd. Details
    • 2.7.2 Yeasen Biotechnology(Shanghai)Co.,Ltd. Major Business
    • 2.7.3 Yeasen Biotechnology(Shanghai)Co.,Ltd. Nanobody Discovery Service Product and Solutions
    • 2.7.4 Yeasen Biotechnology(Shanghai)Co.,Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Yeasen Biotechnology(Shanghai)Co.,Ltd. Recent Developments and Future Plans
  • 2.8 Fortis Life Sciences
    • 2.8.1 Fortis Life Sciences Details
    • 2.8.2 Fortis Life Sciences Major Business
    • 2.8.3 Fortis Life Sciences Nanobody Discovery Service Product and Solutions
    • 2.8.4 Fortis Life Sciences Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Fortis Life Sciences Recent Developments and Future Plans
  • 2.9 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
    • 2.9.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Details
    • 2.9.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Major Business
    • 2.9.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product and Solutions
    • 2.9.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments and Future Plans
  • 2.10 Biointron Biological Inc.
    • 2.10.1 Biointron Biological Inc. Details
    • 2.10.2 Biointron Biological Inc. Major Business
    • 2.10.3 Biointron Biological Inc. Nanobody Discovery Service Product and Solutions
    • 2.10.4 Biointron Biological Inc. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Biointron Biological Inc. Recent Developments and Future Plans
  • 2.11 SAFE Pharmaceutical Technology Co., Ltd.
    • 2.11.1 SAFE Pharmaceutical Technology Co., Ltd. Details
    • 2.11.2 SAFE Pharmaceutical Technology Co., Ltd. Major Business
    • 2.11.3 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Product and Solutions
    • 2.11.4 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 SAFE Pharmaceutical Technology Co., Ltd. Recent Developments and Future Plans
  • 2.12 Abterra Biosciences
    • 2.12.1 Abterra Biosciences Details
    • 2.12.2 Abterra Biosciences Major Business
    • 2.12.3 Abterra Biosciences Nanobody Discovery Service Product and Solutions
    • 2.12.4 Abterra Biosciences Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Abterra Biosciences Recent Developments and Future Plans
  • 2.13 Chengdu Apak Biotechnology Co., Ltd.
    • 2.13.1 Chengdu Apak Biotechnology Co., Ltd. Details
    • 2.13.2 Chengdu Apak Biotechnology Co., Ltd. Major Business
    • 2.13.3 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Product and Solutions
    • 2.13.4 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Chengdu Apak Biotechnology Co., Ltd. Recent Developments and Future Plans
  • 2.14 ICarTab Biomedical Co., Ltd.
    • 2.14.1 ICarTab Biomedical Co., Ltd. Details
    • 2.14.2 ICarTab Biomedical Co., Ltd. Major Business
    • 2.14.3 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Product and Solutions
    • 2.14.4 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 ICarTab Biomedical Co., Ltd. Recent Developments and Future Plans
  • 2.15 Wuhan Daian Biotech Ltd
    • 2.15.1 Wuhan Daian Biotech Ltd Details
    • 2.15.2 Wuhan Daian Biotech Ltd Major Business
    • 2.15.3 Wuhan Daian Biotech Ltd Nanobody Discovery Service Product and Solutions
    • 2.15.4 Wuhan Daian Biotech Ltd Nanobody Discovery Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Wuhan Daian Biotech Ltd Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Nanobody Discovery Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Nanobody Discovery Service by Company Revenue
    • 3.2.2 Top 3 Nanobody Discovery Service Players Market Share in 2025
    • 3.2.3 Top 6 Nanobody Discovery Service Players Market Share in 2025
  • 3.3 Nanobody Discovery Service Market: Overall Company Footprint Analysis
    • 3.3.1 Nanobody Discovery Service Market: Region Footprint
    • 3.3.2 Nanobody Discovery Service Market: Company Product Type Footprint
    • 3.3.3 Nanobody Discovery Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Nanobody Discovery Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Nanobody Discovery Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Nanobody Discovery Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Nanobody Discovery Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Nanobody Discovery Service Consumption Value by Type (2021-2032)
  • 6.2 North America Nanobody Discovery Service Market Size by Application (2021-2032)
  • 6.3 North America Nanobody Discovery Service Market Size by Country
    • 6.3.1 North America Nanobody Discovery Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Nanobody Discovery Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Nanobody Discovery Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Nanobody Discovery Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Nanobody Discovery Service Market Size by Country
    • 7.3.1 Europe Nanobody Discovery Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Nanobody Discovery Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Nanobody Discovery Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Nanobody Discovery Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Nanobody Discovery Service Market Size by Region
    • 8.3.1 Asia-Pacific Nanobody Discovery Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Nanobody Discovery Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Nanobody Discovery Service Consumption Value by Type (2021-2032)
  • 9.2 South America Nanobody Discovery Service Consumption Value by Application (2021-2032)
  • 9.3 South America Nanobody Discovery Service Market Size by Country
    • 9.3.1 South America Nanobody Discovery Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Nanobody Discovery Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Nanobody Discovery Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Nanobody Discovery Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Nanobody Discovery Service Market Size by Country
    • 10.3.1 Middle East & Africa Nanobody Discovery Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Nanobody Discovery Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Nanobody Discovery Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Nanobody Discovery Service Market Drivers
  • 11.2 Nanobody Discovery Service Market Restraints
  • 11.3 Nanobody Discovery Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Nanobody Discovery Service Industry Chain
  • 12.2 Nanobody Discovery Service Upstream Analysis
  • 12.3 Nanobody Discovery Service Midstream Analysis
  • 12.4 Nanobody Discovery Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nanobody Discovery Service market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Nanobody discovery service is a nanobody-based technology for screening and discovering nanobodies with high affinity and specificity. Nanobodies are natural single-chain antibodies that exist in the serum of camelids and sharks . Compared with traditional antibodies, nanobodies have the advantages of small molecular weight, good stability, and strong tissue penetration ability. Because they have no light chain structure, they can be flexibly combined with various antibody molecules. They are used in bispecific antibody drugs and cell therapy drugs. It has broad application prospects in the field of disease diagnosis and treatment, such as diagnosis and detection.
    This report is a detailed and comprehensive analysis for global Nanobody Discovery Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Nanobody Discovery Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Nanobody Discovery Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Nanobody Discovery Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Nanobody Discovery Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nanobody Discovery Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nanobody Discovery Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Biolabs, Curia, Sanofi, NanoTag Biotechnologies, Shanghai Medicilon Inc., Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Yeasen Biotechnology(Shanghai)Co.,Ltd., Fortis Life Sciences, Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Biointron Biological Inc., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Nanobody Discovery Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Screening and Development Services
    Engineering and Optimization Services
    Production and Expression Services
    Other Services
    Market segment by Application
    Drug Discovery
    Biological Engineering
    Clinical Diagnosis
    Immune Research
    Others
    Market segment by players, this report covers
    Creative Biolabs
    Curia
    Sanofi
    NanoTag Biotechnologies
    Shanghai Medicilon Inc.
    Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
    Yeasen Biotechnology(Shanghai)Co.,Ltd.
    Fortis Life Sciences
    Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
    Biointron Biological Inc.
    SAFE Pharmaceutical Technology Co., Ltd.
    Abterra Biosciences
    Chengdu Apak Biotechnology Co., Ltd.
    ICarTab Biomedical Co., Ltd.
    Wuhan Daian Biotech Ltd
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Nanobody Discovery Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Nanobody Discovery Service, with revenue, gross margin, and global market share of Nanobody Discovery Service from 2021 to 2026.
    Chapter 3, the Nanobody Discovery Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Nanobody Discovery Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Nanobody Discovery Service.
    Chapter 13, to describe Nanobody Discovery Service research findings and conclusion.

    Buy now